Search all articles from Emma O'Connor
A clinical trial to test the efficacy and safety of the transplantation of nasal cells to treat chronic spinal cord...
Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine composition designed to be administered via the nose.
Unlocking the secrets behind immune exhaustion in ME/CFS and Long COVID patients.
Griffith and Qantas to establish an Australian-first safety academy.
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University and Gallipoli...
Griffith University has named four winners at its prestigious Outstanding Alumni Awards 2024 ceremony in Brisbane with Leona Murphy taking out the top gong.
Malnutrition continues to be a widespread issue in Australian aged care homes, but Griffith University researchers are striving to address...
A world-first trial to help improve the lives of Australians living with a debilitating spinal cord injury is a step closer with a $6.8 million Medical Research Future Fund grant.
Griffith University’s partnership with PsiQuantum will see a new ‘Test and Validation’ lab opened at Griffith’s Nathan campus. PsiQuantum will...
